Orabloc (Articaine Hydrochloride, Epinephrine)

Articaine, the active ingredient in Orabloc, is a local anesthetic presented as a 4% w/v articaine hydrochloride solution with 1:100,000 epinephrine for intraoral injection use. It provides rapid, profound anesthesia for dental procedures and oral surgery in adult and pediatric patients requiring pain control.

GNH USA supplies Orabloc as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and dental clinics worldwide, providing reliable sourcing for dental anesthetic needs. The product complies with EU regulatory standards and is manufactured under GMP conditions.

Orabloc, containing articaine, is used for local anesthesia in dental and oral surgical procedures.

Tooth extraction: provides rapid onset anesthesia to allow painless removal of the tooth. Periodontal surgery: enables pain‑free manipulation of gingival tissues. Root canal therapy: ensures patient comfort during canal instrumentation. Dental implant placement: facilitates analgesia during implant insertion. Gingival grafting: supplies effective anesthesia for soft‑tissue graft procedures. Oral surgery: delivers controlled pain control for a variety of surgical interventions.

Common Side Effects: - Transient numbness or tingling at the injection site. - Mild swelling or bruising around the area. - Temporary metallic taste. - Light‑headedness or headache. - Slight increase in heart rate. - Minor discomfort during injection.

Serious or Rare Side Effects: - Allergic reaction such as rash, itching, or anaphylaxis. - Methemoglobinemia, presenting with cyanosis. - Seizures due to excessive systemic absorption. - Cardiovascular events including hypertension or arrhythmia. - Prolonged or profound anesthesia persisting beyond expected duration. - Tissue necrosis at the injection site.

Before use, consider the following precautions: - Allergy assessment: confirm no known hypersensitivity to amide‑type local anesthetics or epinephrine. - Dose limitation: adhere to recommended maximum articaine dose per appointment. - Cardiovascular caution: avoid in patients with uncontrolled hypertension or severe cardiac disease. - Pregnancy and lactation: use only if the benefit outweighs potential risk; category unknown. - Drug interactions: review concomitant medications that may potentiate epinephrine effects. - Store below 25°C: keep in the original container, protect from light and moisture.

Articaine may interact with several drug classes. Monitor patients accordingly.

Major Interactions (Avoid): - Non‑selective MAO inhibitors: risk of hypertensive crisis with epinephrine. - Beta‑blockers: may potentiate epinephrine‑induced tachycardia. - Tricyclic antidepressants: increased risk of cardiac arrhythmias.

Moderate Interactions (Monitor Closely):\n- Other local anesthetics: cumulative systemic toxicity. - Sympathomimetic agents (e.g., phenylephrine): additive cardiovascular stimulation. - Diuretics: may enhance epinephrine‑related tachycardia.